ID: ALA1173183

Max Phase: Preclinical

Molecular Formula: C16H17NO

Molecular Weight: 239.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O[C@@H]1Cc2ccccc2N[C@H](c2ccccc2)C1

Standard InChI:  InChI=1S/C16H17NO/c18-14-10-13-8-4-5-9-15(13)17-16(11-14)12-6-2-1-3-7-12/h1-9,14,16-18H,10-11H2/t14-,16+/m1/s1

Standard InChI Key:  MXAMSUMHFVNGPE-ZBFHGGJFSA-N

Associated Targets(Human)

THP-1 11052 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Leishmania chagasi 396 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Trypanosoma cruzi 99888 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Vero 26788 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 239.32Molecular Weight (Monoisotopic): 239.1310AlogP: 3.15#Rotatable Bonds: 1
Polar Surface Area: 32.26Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.39CX LogP: 2.70CX LogD: 2.70
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.80Np Likeness Score: 0.51

References

1. Gómez-Ayala S, Castrillón JA, Palma A, Leal SM, Escobar P, Bahsas A..  (2010)  Synthesis, structural elucidation and in vitro antiparasitic activity against Trypanosoma cruzi and Leishmania chagasi parasites of novel tetrahydro-1-benzazepine derivatives.,  18  (13): [PMID:20627590] [10.1016/j.bmc.2010.05.018]

Source